KKR & Co. Inc. (NYSE:KKR) Given New $148.00 Price Target at Oppenheimer

KKR & Co. Inc. (NYSE:KKR) had its price objective raised by Oppenheimer from $128.00 to $148.00 in a research note released on Wednesday morning, Benzinga reports. Oppenheimer currently has an outperform rating on the asset manager’s stock.

Several other brokerages have also commented on KKR. The Goldman Sachs Group raised their price target on shares of KKR & Co. Inc. from $137.00 to $145.00 and gave the company a “buy” rating in a research note on Thursday, October 3rd. Deutsche Bank Aktiengesellschaft raised their target price on KKR & Co. Inc. from $128.00 to $141.00 and gave the company a “buy” rating in a research report on Thursday, August 1st. Wells Fargo & Company lifted their target price on KKR & Co. Inc. from $130.00 to $139.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 9th. Keefe, Bruyette & Woods reissued an “outperform” rating and issued a $144.00 price target (up previously from $125.00) on shares of KKR & Co. Inc. in a research note on Thursday, August 1st. Finally, Citigroup lifted their price objective on shares of KKR & Co. Inc. from $130.00 to $150.00 and gave the company a “buy” rating in a research note on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, twelve have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $144.43.

KKR & Co. Inc. Price Performance

Shares of KKR opened at $135.67 on Wednesday. KKR & Co. Inc. has a 12 month low of $53.72 and a 12 month high of $137.88. The company has a debt-to-equity ratio of 0.86, a current ratio of 0.07 and a quick ratio of 0.07. The stock has a fifty day moving average price of $125.14 and a 200 day moving average price of $112.12. The company has a market cap of $120.39 billion, a P/E ratio of 30.42, a PEG ratio of 1.14 and a beta of 1.62.

KKR & Co. Inc. (NYSE:KKR) last announced its quarterly earnings results on Wednesday, July 31st. The asset manager reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.20. KKR & Co. Inc. had a net margin of 17.99% and a return on equity of 5.05%. The company had revenue of $4.17 billion during the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter in the previous year, the company posted $0.58 earnings per share. On average, research analysts forecast that KKR & Co. Inc. will post 3.97 earnings per share for the current year.

KKR & Co. Inc. Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, August 27th. Investors of record on Monday, August 12th were issued a dividend of $0.175 per share. This represents a $0.70 dividend on an annualized basis and a yield of 0.52%. The ex-dividend date of this dividend was Monday, August 12th. KKR & Co. Inc.’s payout ratio is 15.70%.

Insider Buying and Selling at KKR & Co. Inc.

In other news, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the firm’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $25.75, for a total transaction of $149,350,000.00. Following the completion of the sale, the insider now directly owns 25,260,971 shares of the company’s stock, valued at $650,470,003.25. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. In other news, major shareholder Kkr Group Partnership L.P. bought 11,619,998 shares of the business’s stock in a transaction on Wednesday, September 11th. The shares were bought at an average cost of $11.13 per share, with a total value of $129,330,577.74. Following the purchase, the insider now directly owns 92,959,984 shares in the company, valued at $1,034,644,621.92. This trade represents a 0.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, major shareholder Genetic Disorder L.P. Kkr sold 5,800,000 shares of the company’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $25.75, for a total value of $149,350,000.00. Following the transaction, the insider now directly owns 25,260,971 shares in the company, valued at $650,470,003.25. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 39.34% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On KKR & Co. Inc.

Several institutional investors and hedge funds have recently bought and sold shares of KKR. Centaurus Financial Inc. purchased a new position in KKR & Co. Inc. during the fourth quarter valued at approximately $119,000. EP Wealth Advisors LLC raised its holdings in shares of KKR & Co. Inc. by 36.8% during the fourth quarter. EP Wealth Advisors LLC now owns 5,622 shares of the asset manager’s stock worth $466,000 after acquiring an additional 1,512 shares in the last quarter. SageView Advisory Group LLC acquired a new stake in KKR & Co. Inc. during the fourth quarter valued at $357,000. HighPoint Advisor Group LLC purchased a new position in KKR & Co. Inc. in the fourth quarter valued at about $402,000. Finally, Fulton Bank N.A. increased its position in KKR & Co. Inc. by 1.5% in the 1st quarter. Fulton Bank N.A. now owns 13,568 shares of the asset manager’s stock worth $1,365,000 after purchasing an additional 201 shares during the last quarter. Hedge funds and other institutional investors own 76.26% of the company’s stock.

KKR & Co. Inc. Company Profile

KKR & Co Inc is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market and middle market investments.